ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
This educational activity is designed to provide a learning environment that provides interactive discussions on up to date medical information, treatment plans, options and protocols, along with the risks, benefits and outcomes of treatment on adult musculoskeletal oncology patients. This is a discussed in a multidisciplinary format that creates a well rounded unbiased discussion amongst colleagues. It creates an environment for dynamic discussion and debates on patient care and the treatment resources available. It provides the opportunity for consistent tailored individual treatment protocols per patient.
NCCN and other national guidelines are used in patient treatment planning unless otherwise stated by the physician
Allied Health Care Professionals
- Apply recent updates to treatment plans and protocols based on the discussions of the patient’s treatment at tumor board
- Expand our discussions to include the most recent and relevant literature evaluations on musculoskeletal oncology and disease protocols and treatment outcomes
- Continue to collaborate as a multidisciplinary unit to treat the patient as a whole and utilize treatment resources efficiently
- Publish research that is up to date and relevant to current literature
Planning Committee and Program Directors:
Activity Director(s): Don Hackbarth, MD, David King, MD and Lori Hollingsworth-Burds, PA-C
In accordance with the ACCME policy on relevant financial disclosure, the following planners disclosed that they have the following commercial interests. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Dr. P. Rossi, Silk Road Medical and Terumo Aortic, speaker
Dr. D. Hackbarth, Musculoskeletal Transplant Foundation, Board of Directors
Dr. J.C. Neilson, Musculoskeletal Transplant Foundation, Board of Trustees, Siemens, Research Support
Dr. J. Charlson, Immune Design, Administration Baord, Lilly, Research Trial Funding
Dr. S. Tutton, Benvenue, Consultant, Siemens, Research Support, BTG, Consultant
All others in control of content had NO relevant financial relationships to disclose.
Drs. K. Baynes, M. Bedi, G. Carrera, R. Cerniglia, J. Charlson, M. Du Bois, S. Erickson, D. King, J. LoGiudice, A. MacKinnon, R. Mannem, J. Neilson, C. Johnstone, D. Johnstone, P. Rossi, S. Suster, S. Tutton, C. Clarke, H. Mogal, W. Lea, B. Rebholz, M. Stetz, J. Symanski, M. Vickery, A. Wooldridge, L. Hollingsworth-Burds PA-C, S. Veenendaal PA-C, J. Waugh APNP MSN, K. Horness PA-C., J. Merrill, NP
All persons in control of content have NO relevant financial relationships to disclose.